| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |